Your browser doesn't support javascript.
loading
Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium.
Koivula, Robert W; Forgie, Ian M; Kurbasic, Azra; Viñuela, Ana; Heggie, Alison; Giordano, Giuseppe N; Hansen, Tue H; Hudson, Michelle; Koopman, Anitra D M; Rutters, Femke; Siloaho, Maritta; Allin, Kristine H; Brage, Søren; Brorsson, Caroline A; Dawed, Adem Y; De Masi, Federico; Groves, Christopher J; Kokkola, Tarja; Mahajan, Anubha; Perry, Mandy H; Rauh, Simone P; Ridderstråle, Martin; Teare, Harriet J A; Thomas, E Louise; Tura, Andrea; Vestergaard, Henrik; White, Tom; Adamski, Jerzy; Bell, Jimmy D; Beulens, Joline W; Brunak, Søren; Dermitzakis, Emmanouil T; Froguel, Philippe; Frost, Gary; Gupta, Ramneek; Hansen, Torben; Hattersley, Andrew; Jablonka, Bernd; Kaye, Jane; Laakso, Markku; McDonald, Timothy J; Pedersen, Oluf; Schwenk, Jochen M; Pavo, Imre; Mari, Andrea; McCarthy, Mark I; Ruetten, Hartmut; Walker, Mark; Pearson, Ewan; Franks, Paul W.
Afiliação
  • Koivula RW; Department of Clinical Sciences, Lund University Diabetes Centre, Genetic and Molecular Epidemiology Unit, CRC, Skåne University Hospital Malmö, Building 91, Level 10, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.
  • Forgie IM; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Kurbasic A; Population Health & Genomics, Medical Research Institute, University of Dundee, Dundee, DD1 9SY, UK.
  • Viñuela A; Department of Clinical Sciences, Lund University Diabetes Centre, Genetic and Molecular Epidemiology Unit, CRC, Skåne University Hospital Malmö, Building 91, Level 10, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.
  • Heggie A; Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
  • Giordano GN; Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland.
  • Hansen TH; Swiss Institute of Bioinformatics, Geneva, Switzerland.
  • Hudson M; Institute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, UK.
  • Koopman ADM; Department of Clinical Sciences, Lund University Diabetes Centre, Genetic and Molecular Epidemiology Unit, CRC, Skåne University Hospital Malmö, Building 91, Level 10, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.
  • Rutters F; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
  • Siloaho M; NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK.
  • Allin KH; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands.
  • Brage S; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands.
  • Brorsson CA; Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  • Dawed AY; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
  • De Masi F; Department of Clinical Epidemiology, Bispebjerg and Frederiksberg Hospital, the Capital Region, Copenhagen, Denmark.
  • Groves CJ; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Kokkola T; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Mahajan A; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
  • Perry MH; Population Health & Genomics, Medical Research Institute, University of Dundee, Dundee, DD1 9SY, UK.
  • Rauh SP; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
  • Ridderstråle M; Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  • Teare HJA; Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  • Thomas EL; Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
  • Tura A; NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK.
  • Vestergaard H; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands.
  • White T; Department of Clinical Sciences, Clinical Obesity, Skåne University Hospital Malmö, Lund University, Malmö, Sweden.
  • Adamski J; Novo Nordisk A/S, Søborg, Denmark.
  • Bell JD; HeLEX, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, UK.
  • Beulens JW; Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, UK.
  • Brunak S; Institute of Neurosciences, National Research Council, Padova, Italy.
  • Dermitzakis ET; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
  • Froguel P; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Frost G; Institute of Epidemiology II, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
  • Gupta R; Research Centre for Optimal Health, Department of Life Sciences, University of Westminster, London, UK.
  • Hansen T; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, the Netherlands.
  • Hattersley A; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
  • Jablonka B; The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
  • Kaye J; Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
  • Laakso M; Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland.
  • McDonald TJ; Swiss Institute of Bioinformatics, Geneva, Switzerland.
  • Pedersen O; Department of Genomics of Common Disease, School of Public Health, Imperial College London, London, UK.
  • Schwenk JM; CNRS, Pasteur Institute of Lille, University of Lille, Lille, France.
  • Pavo I; Nutrition and Dietetics Research Group, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Campus, London, UK.
  • Mari A; Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
  • McCarthy MI; The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
  • Ruetten H; Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Walker M; NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK.
  • Pearson E; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
  • Franks PW; Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany.
Diabetologia ; 62(9): 1601-1615, 2019 09.
Article em En | MEDLINE | ID: mdl-31203377
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Biomarcadores / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glicemia / Biomarcadores / Diabetes Mellitus Tipo 2 Tipo de estudo: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suécia